| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, December 2007, p. 8038-8048, Vol. 27, No. 23
0270-7306/07/$08.00+0 doi:10.1128/MCB.01046-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Department of Immunology, University of Toronto, Medical Sciences Bldg., Toronto, Canada M5S 1A8
Received 13 June 2007/ Returned for modification 6 August 2007/ Accepted 12 September 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
AID activity is believed to be regulated through interaction with cofactors (8) and through posttranslational modification (3, 33, 38). On the other hand, the basic enzymatic properties of AID itself are also crucial determinants of its activity. First, we and others found that purified AID preferentially mutates cytidines in WRC motifs (W is A or T; R is A or G) (24, 25, 41, 58). Findings that CSR breakpoints occur at WRC motifs (22, 61) and that this specificity is highly conserved (53) argue that the sequence preference inherent to AID plays a significant biological role. Second, AID deaminates ssDNA processively in vitro (41), and evidence for this type of activity has been documented for mice (55). Third, we recently showed that AID binds single-stranded or bubble-type DNA substrates with high affinity and a long half-life, irrespective of nucleotide sequence (25).
The mechanism that targets AID to immunoglobulin (Ig) genes is not known. Although cis-acting sequences that reside within the Ig locus have long been suspected to exist, data in support of this notion are currently incomplete. Recent developments have suggested that proteins that bind to e-box motifs (34) or the Ig promoter itself (56) help localize AID to Ig sequences. Indeed, it has been well documented that AID-generated mutation rates correlate with the transcriptional rate of target genes (2, 39) and that transcribed double-stranded DNA (dsDNA) is subject to AID activity in Escherichia coli, in mammalian cell lines, and in vitro (9, 21, 27, 29, 45). Despite this strong correlation with transcription, the precise nature of the in vivo AID substrate is unknown. It has been postulated that AID acts directly on the ssDNA of transcription bubbles (8, 31, 45, 51) or on R-loops formed between long-lived RNA-DNA hybrids (57, 59). In support of this notion, deoxyuridines have been reported to be generated preferentially in the nontranscribed strand (32, 45, 62), as would be predicted due to the "protection" offered by the nascent RNA strand. However, other groups find that both strands are more or less mutated equally in vivo (55) and in vitro (5, 49, 50). Alternatively, positive supercoiling induced downstream of the transcriptional machinery can generate stem-loop or G4 DNA structures (18, 44, 54), while negative supercoiling induced upstream of the RNA polymerase can also cause local unwinding of the DNA, creating ssDNA structures (15, 28). Thus, since transcription can generate multiple DNA structures, it is not clear which of these are the in vivo targets of AID. Furthermore, the architectural requirements of WRC specificity have not been examined in detail. For instance, while it is known that AID mutates cytidines in ssDNA (7), it is not known whether only the cytidine or the entire WRC motif is required to be single-stranded in order to be deaminated by AID. This distinction is particularly important, since some DNA binding proteins exhibit nucleotide sequence specificity in the context of dsDNA (e.g., DNA-binding transcription factors) (48) while others do so on ssDNA (e.g., NF-GMb and H16) (14, 19). To address these issues, we measured the catalytic preference and binding kinetics of AID for various DNA structures.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Substrate preparation.
The bubble substrates are similar to those previously described (25) (Fig. 1A). 5' labeling was done using [
-32P]dATP and polynucleotide kinase (New England Biolabs [NEB]) followed by purification through mini-Quick spin DNA columns (Roche). A 2.5-pmol amount of the labeled strand was mixed with at least a twofold excess of the cold strand in a volume of 25 µl and annealed by slow cooling from 94°C. The stem-loop substrates were labeled and purified in a similar manner, but self-annealing was done in a 125-µl volume by heating to 95°C and snap-cooling. In order to verify their structure, 20 fmol of stem-loop substrate was digested with 1 U of BamHI in a volume of 20 µl for 1 h at 37°C (Fig. 2B). A single-stranded oligonucleotide containing a BamHI site was used to ensure that any BamHI cleavage was due to the presence of a double-stranded recognition sequence.
|
|
EMSA. Detection of AID binding using an electrophoretic mobility shift assay (EMSA) has been previously described (25). Briefly, labeled substrate was incubated with 0.3 to 1 µg GST-AID in 50 mM Tris (pH 7.5), 2.0 µM MgCl, 50 mM NaCl, and 1 mM dithiothreitol in a final volume of 10 µl at 25°C for 45 min. Samples were then UV cross-linked (Stratagene) on ice at a distance of 2 cm from the UV source with 100 mJ and an irradiation time of 50 s. Samples were electrophoresed at 4°C on 8% native gels and visualized using a PhosphorImager (Molecular Dynamics). Gel quantitation was done using ImageQuant 5.0 software (Molecular Dynamics). Duplicate gels were used to obtain accurate average values of bound and free fractions at each substrate concentration. Data were plotted as bound and free fractions of the substrate. Graphpad Prism 5.0 software was used to fit the data to the equation derived from the law of mass action, [bound] = ([boundmax] x [free])/(Kd + [free]) (where [bound] is the concentration of bound fraction, [free] is the concentration of free fraction, [boundmax] is the maximum concentration of bound fraction, and Kd is the binding affinity of AID for the substrate) for the determination of approximate half-saturation values. The determination of complex half-life values was performed as previously mentioned (25). Briefly, binding reactions were set up using 10 fmol of radioactively labeled substrate and incubated for 45 min to allow for complex formation. A thousandfold excess (10 pmol) of unlabeled substrate was added to the binding mixture, followed by incubation for various lengths of time to allow for dissociation of AID from the labeled substrate prior to UV cross-linking of the reaction. Graphpad Prism 5.0 was used to fit the data to an exponential-decay model for the determination of complex half-life values.
MBN treatment of bubble substrates. Labeled bubble-type substrate (50 fmol) was incubated with 0.1 or 1 U of mung bean nuclease (MBN) (NEB) in a buffer containing 50 mM sodium acetate, 30 mM NaCl, 1 mM ZnSO4 (pH 5.0) for 2 to 5 min at 37°C in a final volume of 10 µl. Reactions were stopped by the addition of 200 mM EDTA-10 mM ATP, pH 9.0 (4), electrophoresed on denaturing acrylamide gels, and visualized using a PhosphorImager (Molecular Dynamics).
Statistical analysis. Each point on a velocity-versus-substrate-concentration plot was obtained from at least two independent experiments. Data were analyzed by using GraphPad Prism version 5.0. A two-way analysis-of-variance test was used for statistical analysis of the deamination assays, and one-way analysis-of-variance and Tukey's multiple comparisons tests were used for the EMSA data.
| RESULTS |
|---|
|
|
|---|
AID activity is reduced on stem-loop structures. The preference of AID for small bubble-type structures as well as the high frequency of inverted repeat sequences in the immunoglobulin genes (21) raise the possibility that stem-loop structures generated through DNA unwinding during transcription may be the in vivo targets of AID rather than the transcription bubble itself (6, 9, 50). In order to test this possibility, we generated stem-loop structures of 1 (GGC S1), 3 (AGC S3), 7 (AGC S7), 9 (AGC S9), and 13 (AGC S13) nt, with the latter four containing WRC motifs (Fig. 2A). In order to verify that the proper stem-loop structure was achieved, the annealed stem-loop structures were designed with a BamHI restriction site in the stem region (Fig. 2A). Complete BamHI digestion indicated the formation of a double-stranded stem (Fig. 2B). Furthermore, the presence of a single band of the appropriate size upon native electrophoresis indicated that the annealed stem-loops were of a uniform monomolecular, nonconcatamerized structure (Fig. 2C; also data not shown). As shown in Fig. 2D, AID activity was significantly diminished on the stem-loop substrates compared to that on AGC bub7, indicating that AID prefers to deaminate bubble substrates.
High-affinity binding is required for AID activity. We previously showed that AID bound to bubble substrates with high affinity (i.e., nanomolar range) (25). To determine whether high-affinity binding is necessary for deamination, we used EMSAs to measure the bound and free fractions of substrate over a range of substrate concentrations in order to calculate the binding affinity (i.e., Kd) of AID for substrates that were poorly deaminated (i.e., bub2, bub3, S3, S7, S9, and S13). A typical EMSA experiment is shown in Fig. 3A. While the half-saturation (Kd) values obtained for binding to 2- and 3-nt bubbles (Fig. 3B) were approximately threefold higher than those measured on a 7-nt bubble (i.e., 4.51 ± 1.84 nM, 4.55 ± 3.90 nM, and 1.41 ± 0.58 nM, respectively), the amount of bound substrate was 5- to 10-fold lower than that with a 7-nt bubble (a point which will be addressed below; see Discussion). We compared AID binding to bubble and stem-loop substrates by measuring half-saturation values and the time of complex half-life. As shown in Fig. 3C, higher levels of complex were generated on the AGC bub7, AGC S7, S9, and S13 substrates than on AGC S3. However, binding saturation was not achieved with the stem-loop substrates (i.e., Kd of >10 nM for AGC S3 and S7, S9, and S13), indicating that AID binds stem-loop substrates with at least a 10-fold-lower binding affinity than that for AGC bub7. Complex decay studies indicated that the half-life of AID bound to AGC bub7 was approximately 10 min (Fig. 3D), in agreement with our previous findings (25). In contrast, AID bound to AGC S7 with a half-life of approximately 2 min (Fig. 3D). Taken together, these results indicate that lower binding affinities and lower levels of bound complex result in decreased AID activity.
|
|
Since we found that the deamination was strongly inhibited if the WR motif was placed within the dsDNA region of a bubble, we tested whether the WR motif could be placed in ssDNA but on the opposite strand of the bubble (Fig. 4D, upper panel). We designed target bubble structures in which the sequence of the top (cold) strand was varied to form WRC or non-WRC motifs in trans with respect to the target cytidine located on the bottom strand (Fig. 4D, upper panel). We found that AID activity on the target cytidine was not affected by the WR sequence of the top strand (Fig. 4D, lower panel), indicating that WRC preference must be enforced 5' to 3' in the context of the same DNA strand.
Recognition of specific nucleotide side chain groups by AID. Although we have previously shown that the WRC specificity of AID represents a catalytic rather than a binding preference (25), the reason for this specificity is unknown. AID's preference for R nucleotides (i.e., A or G) in the –1 position relative to the cytidine could simply reflect a requirement for a purine rather than a pyrimidine at this position. However, the reasons for AID's preference of a W nucleotide (i.e., A or T) in the –2 position relative to the cytidine are less clear, since one purine (A) or pyrimidine (T) generates a hot spot while the other purine (G) or pyrimidine (C) results in a cold spot. In order to gain insight into the WRC specificity of AID, we utilized the purine analogues inosine and 2-aminopurine in catalytic assays described above. As shown in Fig. 5A, inosine and 2-aminopurine resemble G, with the former harboring the carbonyl group and the latter the amino group of G. We reasoned that substitution of A or G by either of these purine analogues would facilitate the identification of the purine features that are important for AID activity in the –1 and –2 positions. Thus, we created 7-nt bubble substrates (similar to TGC bub7, shown in Fig. 1A) in which we inserted inosine or 2-aminopurine in the –1 or –2 positions relative to the cytidine in various combinations and assessed AID deamination in parallel with conventional WRC and non-WRC substrates.
|
| DISCUSSION |
|---|
|
|
|---|
We found that deamination was optimal on 5-nt bubble substrates, undetectable or very weak on 1- to 3-nt bubble substrates or stem-loop substrates of 3 to 13 nt, and reduced on larger bubbles of 9 to 13 nt. Our finding that 7-nt bubbles contained transiently ssDNA at the dsDNA junctions (Fig. 4D) suggests that 3-nt bubbles would also be subject to this effect and thus the poor but measurable activity on 3-nt bubbles could simply reflect AID's deamination of "breathing" 3-nt bubbles. This would indicate that the minimal DNA binding/catalytic domain for AID is likely greater than 3 nt in length. Although our work argues against AID deaminating stem-loop structures in vivo, we cannot exclude the possibility that larger stem-loops or R-loops may be acted on by AID. However, based on the results shown here, bubble, stem-loop, or R-loop structures greater than 7 nt in length are probably recognized by AID as less efficiently ssDNA and than small bubbles, possibly due to the more rigid structure of the latter. An earlier report showed that the optimal substrate for AID activity was a 9-nt bubble substrate (7), a discrepancy that we propose might be due to different preparations of AID or various reaction conditions. Additionally, we found that AID activity levels may appear similar at low substrate concentrations and differences may become apparent only when enzymatic velocities are examined over a wide range of substrate concentrations, which can also explain this discrepancy. We suggest that since transcription bubbles are proposed to be
18 nt long (12), with the majority of their length occupied by the elongation complex, the preference of AID for deamination of WRC motifs in 5-nt-long bubbles reflects its optimization for targeting the accessible regions of the transcription bubble. Alternatively, AID may have evolved to react with small regions of transcription-induced denatured DNA, as was recently observed for hypermutating genes (47).
As mentioned in the introduction, current literature has not addressed whether the WR motif must also be fully single stranded. That is, significant data show that AID can react with WRC motifs in ssDNA but don't rule out that AID can react with a WRC motif which is only partially located in ssDNA, such as would occur at the edges of DNA gaps or transcription bubble junctions in vivo. To this end, we examined whether the WR motif can be recognized in dsDNA as well as ssDNA. By using bubble substrates in which the position of the target cytidine was varied as well as substrates in which the WR motif was placed in the stem rather than the bubble region, we showed that the most efficient deamination target consisted of a WRC motif flanked by ssDNA. This result indicates that in contrast to sequence-specific dsDNA recognition enzymes (e.g., restriction endonucleases and transcription factors), AID is not capable of discerning nucleotide features in dsDNA.
The significance of binding affinity for AID activity. To understand why some structures are preferentially deaminated over other substrates, we examined whether AID binding affinity correlates with deamination activity. First, we found that stem-loop substrates, which were poorly deaminated by AID, were also bound by AID with lower affinity than was the case with optimal substrates (i.e., 5- to 7-nt bubble substrates). The notable difference in AID binding between a 7-nt bubble and a 7-nt stem-loop substrate suggests that AID can discern specific shape differences, possibly due to DNA bending. Second, we found that 2- or 3-nt bubbles, which were poorly deaminated by AID, exhibit highly diminished boundmax values despite only slightly reduced affinity compared to that for bub7. This indicates heterogeneity in the substrate or the enzyme pool, such that a smaller fraction of the substrate is bound. As discussed above, since the bubble substrates contain ss/dsDNA junctions which are "breathing," we believe that the lower boundmax values obtained with 3-nt bubbles are due to AID interacting with "opened-up" bubbles that exist at a constant but low concentration relative to the "closed" 3-nt length bubbles. Collectively, our data suggest that high-affinity binding of AID to DNA substrates is required for efficient deamination in vitro. Definitive confirmation of this notion would require in vitro and in vivo data correlating substrate affinity with activity using mutants of AID.
Our finding that AID binds ssDNA with high affinity provides an explanation for AID processivity (41). That is, because AID binds rapidly and dissociates slowly, it is more likely to bind the same substrate molecule after dissociation (25, 42), thus accounting for the short-track processivity of AID (13). Substrate "jumping" has also been shown to account for the processive-like behavior of some restriction endonucleases (52), in contrast to substrate "sliding," which accounts for the processivity of polymerases (10). Nonetheless, formal proof is lacking that AID processivity is necessary for biological function, and this might be satisfied by the experiments mentioned in the previous paragraph.
Target requirements for WRC preference. Since direct analysis of the AID catalytic site is not yet possible due to the lack of an X-ray crystal structure, we aimed to gain insight into the mechanism of WRC specificity by understanding the specific nucleotide side chains that are of importance for the recognition of a WRC by AID. By using the purine analogues inosine and 2-aminopurine in the –1 position in combination with a natural W (A or T) in the –2 position relative to the target cytidine, we showed that both analogues support efficient deamination. This indicates that AID prefers any purine at the –1 position. However, as noted in Results, the nucleotide preference of AID at the –2 position is paradoxical. We found that when placed in the –2 position in combination with natural R nucleotides (i.e., A or G) in the –1 position, both inosine and 2-aminopurine functioned similarly to a G, rather than A. This indicates either that the amino moiety of A is recognized by the catalytic site of AID in this position or that the carbonyl and amino moieties of G are a hindrance to recognition. The former model would predict that G, inosine, and 2-aminopurine would all be equally inefficient at supporting deamination. However, our observation that in the –2 position G is slightly less efficient than either inosine or 2-aminopurine, each of which carries only one of its side chains, supports the latter model. Overall, the result that no trinucleotide combination with an analogue was a significantly better deamination substrate than natural WRC motifs indicates that the catalytic site of AID is optimized for its natural targets in vivo. We propose that the catalytic site of AID possesses two recognition pockets for the –2 position, one that fits the purine A and one that fits the pyrimidine T. Since any purine could support efficient deamination in the –1 position, this suggests that interactions between AID and DNA might occur on shared groups between purines via involvement of amino acids such as Asn, Gln, Ser, Thr, Tyr, Arg, and Lys, all of which are thought to form hydrogen bonds with the pentamer or hexamer backbone of purines (11). However, our finding that AID's preference for a nucleotide in the –1 position depended on which nucleotide was present in the –2 position (i.e., preference for T2C over TIC but preference for AIC over A2C) suggests that different amino acid side chains of the –1 pocket of AID prefer different purine side chains, such that depending on which –2 pocket is occupied, either a carbonyl or an amino side chain bearing purine is preferred in the –1 position. We note that this model represents the simplest scenario for an AID catalytic site compatible with the current in vitro data but that alternative models are possible, since stacking interactions between adjacent nucleotides and the recognition of a dinucleotides motif by a single amino acid may be important.
| ACKNOWLEDGMENTS |
|---|
This research was funded by a grant from the Canadian Institute of Health Research to A.M., who is supported by a Canada Research Chair award. M.L. was supported by the David Rae Memorial Award from the Leukemia and Lymphoma Society of Canada and is presently supported by a Terry Fox Foundation award from the National Cancer Institute of Canada.
| FOOTNOTES |
|---|
Published ahead of print on 24 September 2007. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Bachl, J., C. Carlson, V. Gray-Schopfer, M. Dessing, and C. Olsson. 2001. Increased transcription levels induce higher mutation rates in a hypermutating cell line. J. Immunol. 166:5051-5057.
3. Basu, U., J. Chaudhuri, C. Alpert, S. Dutt, S. Ranganath, G. Li, J. P. Schrum, J. P. Manis, and F. W. Alt. 2005. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438:508-511.[CrossRef][Medline]
4. Baumann, U., and S. Chang. 1995. Asymmetric structure of five and six membered DNA hairpin loops. Mol. Biol. Rep. 22:25-31.[CrossRef][Medline]
5. Besmer, E., E. Market, and F. N. Papavasiliou. 2006. The transcription elongation complex directs activation-induced cytidine deaminase-mediated DNA deamination. Mol. Cell. Biol. 26:4378-4385.
6. Bransteitter, R., P. Pham, P. Calabrese, and M. F. Goodman. 2004. Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279:51612-51621.
7. Bransteitter, R., P. Pham, M. D. Scharff, and M. F. Goodman. 2003. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100:4102-4107.
8. Chaudhuri, J., C. Khuong, and F. W. Alt. 2004. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430:992-998.[CrossRef][Medline]
9. Chaudhuri, J., M. Tian, C. Khuong, K. Chua, E. Pinaud, and F. W. Alt. 2003. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422:726-730.[CrossRef][Medline]
10. Chen, X., S. Zuo, Z. Kelman, M. O'Donnell, J. Hurwitz, and M. F. Goodman. 2000. Fidelity of eucaryotic DNA polymerase delta holoenzyme from Schizosaccharomyces pombe. J. Biol. Chem. 275:17677-17682.
11. Cheng, A. C., W. W. Chen, C. N. Fuhrmann, and A. D. Frankel. 2003. Recognition of nucleic acid bases and base-pairs by hydrogen bonding to amino acid side-chains. J. Mol. Biol. 327:781-796.[CrossRef][Medline]
12. Choder, M., and Y. Aloni. 1988. RNA polymerase II allows unwinding and rewinding of the DNA and thus maintains a constant length of the transcription bubble. J. Biol. Chem. 263:12994-13002.
13. Coker, H. A., and S. K. Petersen-Mahrt. 2007. AID's distributive mode of action: a definition. DNA Repair (Amsterdam) 6:693-694.[CrossRef]
14. Coles, L. S., F. Occhiodoro, M. A. Vadas, and M. F. Shannon. 1994. A sequence-specific single-strand DNA binding protein that contacts repressor sequences in the human GM-CSF promoter. Nucleic Acids Res. 22:4276-4283.
15. Collins, I., A. Weber, and D. Levens. 2001. Transcriptional consequences of topoisomerase inhibition. Mol. Cell. Biol. 21:8437-8451.
16. Dickerson, S. K., E. Market, E. Besmer, and F. N. Papavasiliou. 2003. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197:1291-1296.
17. Di Noia, J., and M. S. Neuberger. 2002. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419:43-48.[CrossRef][Medline]
18. Duquette, M. L., P. Handa, J. A. Vincent, A. F. Taylor, and N. Maizels. 2004. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev. 18:1618-1629.
19. Gaillard, C., and F. Strauss. 1990. Sequence-specific single-strand-binding protein for the simian virus 40 early promoter stimulates transcription in vitro. J. Mol. Biol. 215:245-255.[CrossRef][Medline]
20. Harris, R. S., J. E. Sale, S. K. Petersen-Mahrt, and M. S. Neuberger. 2002. AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12:435-438.[CrossRef][Medline]
21. Honjo, T., K. Kinoshita, and M. Muramatsu. 2002. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20:165-196.[CrossRef][Medline]
22. Huang, F. T., K. Yu, C. L. Hsieh, and M. R. Lieber. 2006. Downstream boundary of chromosomal R-loops at murine switch regions: implications for the mechanism of class switch recombination. Proc. Natl. Acad. Sci. USA 103:5030-5035.
23. Larijani, M., S. Chen, L. A. Cunningham, J. M. Volpe, L. G. Cowell, S. M. Lewis, and G. E. Wu. 2006. The recombination difference between mouse kappa and lambda segments is mediated by a pair-wise regulation mechanism. Mol. Immunol. 43:870-881.[CrossRef][Medline]
24. Larijani, M., D. Frieder, W. Basit, and A. Martin. 2005. The mutation spectrum of purified AID is similar to the mutability index in Ramos cells and in ung(–/–)msh2(–/–) mice. Immunogenetics 56:840-845.[CrossRef][Medline]
25. Larijani, M., A. P. Petrov, O. Kolenchenko, M. Berru, S. N. Krylov, and A. Martin. 2007. AID associates with single-stranded DNA with high affinity and a long complex half-life in a sequence-independent manner. Mol. Cell. Biol. 27:20-30.
26. Lee, A. I., S. D. Fugmann, L. G. Cowell, L. M. Ptaszek, G. Kelsoe, and D. G. Schatz. 2003. A functional analysis of the spacer of V(D)J recombination signal sequences. PLoS Biol. 1:E1.[Medline]
27. Li, Z., C. J. Woo, M. D. Iglesias-Ussel, D. Ronai, and M. D. Scharff. 2004. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 18:1-11.
28. Liu, L. F., and J. C. Wang. 1987. Supercoiling of the DNA template during transcription. Proc. Natl. Acad. Sci. USA 84:7024-7027.
29. Longerich, S., A. Tanaka, G. Bozek, D. Nicolae, and U. Storb. 2005. The very 5' end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J. Exp. Med. 202:1443-1454.
30. Martin, A., P. D. Bardwell, C. J. Woo, M. Fan, M. J. Shulman, and M. D. Scharff. 2002. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802-806.[Medline]
31. Martin, A., and M. D. Scharff. 2002. AID and mismatch repair in antibody diversification. Nat. Rev. Immunol. 2:605-614.[Medline]
32. Martomo, S. A., D. Fu, W. W. Yang, N. S. Joshi, and P. J. Gearhart. 2005. Deoxyuridine is generated preferentially in the nontranscribed strand of DNA from cells expressing activation-induced cytidine deaminase. J. Immunol. 174:7787-7791.
33. McBride, K. M., A. Gazumyan, E. M. Woo, V. M. Barreto, D. F. Robbiani, B. T. Chait, and M. C. Nussenzweig. 2006. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103:8798-8803.
34. Michael, N., H. M. Shen, S. Longerich, N. Kim, A. Longacre, and U. Storb. 2003. The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19:235-242.[CrossRef][Medline]
35. Montalbano, A., K. M. Ogwaro, A. Tang, A. G. Matthews, M. Larijani, M. A. Oettinger, and A. J. Feeney. 2003. V(D)J recombination frequencies can be profoundly affected by changes in the spacer sequence. J. Immunol. 171:5296-5304.
36. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.[CrossRef][Medline]
37. Okazaki, I. M., K. Kinoshita, M. Muramatsu, K. Yoshikawa, and T. Honjo. 2002. The AID enzyme induces class switch recombination in fibroblasts. Nature 416:340-345.[CrossRef][Medline]
38. Pasqualucci, L., Y. Kitaura, H. Gu, and R. Dalla-Favera. 2006. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103:395-400.
39. Peters, A., and U. Storb. 1996. Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4:57-65.[CrossRef][Medline]
40. Petersen-Mahrt, S. K., R. S. Harris, and M. S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418:99-104.[Medline]
41. Pham, P., R. Bransteitter, J. Petruska, and M. F. Goodman. 2003. Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424:103-107.[CrossRef][Medline]
42. Pham, P., L. Chelico, and M. F. Goodman. 2007. DNA deaminases AID and APOBEC3G act processively on single-stranded DNA. DNA Repair (Amsterdam) 6:689-692.[CrossRef]
43. Rada, C., G. T. Williams, H. Nilsen, D. E. Barnes, T. Lindahl, and M. S. Neuberger. 2002. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 12:1748-1755.[CrossRef][Medline]
44. Rahmouni, A. R., and R. D. Wells. 1992. Direct evidence for the effect of transcription on local DNA supercoiling in vivo. J. Mol. Biol. 223:131-144.[CrossRef][Medline]
45. Ramiro, A. R., P. Stavropoulos, M. Jankovic, and M. C. Nussenzweig. 2003. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 14:14.
46. Revy, P., T. Muto, Y. Levy, F. Geissmann, A. Plebani, O. Sanal, N. Catalan, M. Forveille, R. Dufourcq-Labelouse, A. Gennery, I. Tezcan, F. Ersoy, H. Kayserili, A. G. Ugazio, N. Brousse, M. Muramatsu, L. D. Notarangelo, K. Kinoshita, T. Honjo, A. Fischer, and A. Durandy. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565-575.[CrossRef][Medline]
47. Ronai, D., M. D. Iglesias-Ussel, M. Fan, Z. Li, A. Martin, and M. D. Scharff. 2007. Detection of chromatin-associated single-stranded DNA in regions targeted for somatic hypermutation. J. Exp. Med. 204:181-190.
48. Rosenberg, J. M., H. W. Boyer, and P. Greene. 1981. The structure and function of the EcoRI restriction endonuclease. Gene Amplif. Anal. 1:131-164.[Medline]
49. Shen, H. M., S. Ratnam, and U. Storb. 2005. Targeting of the activation-induced cytosine deaminase is strongly influenced by the sequence and structure of the targeted DNA. Mol. Cell. Biol. 25:10815-10821.
50. Shen, H. M., and U. Storb. 2004. Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl. Acad. Sci. USA 101:12997-13002.
51. Sohail, A., J. Klapacz, M. Samaranayake, A. Ullah, and A. S. Bhagwat. 2003. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31:2990-2994.
52. Stanford, N. P., M. D. Szczelkun, J. F. Marko, and S. E. Halford. 2000. One- and three-dimensional pathways for proteins to reach specific DNA sites. EMBO J. 19:6546-6557.[CrossRef][Medline]
53. Wakae, K., B. G. Magor, H. Saunders, H. Nagaoka, A. Kawamura, K. Kinoshita, T. Honjo, and M. Muramatsu. 2006. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID. Int Immunol. 18:41-47.
54. Wang, Z., and P. Droge. 1997. Long-range effects in a supercoiled DNA domain generated by transcription in vitro. J. Mol. Biol. 271:499-510.[CrossRef][Medline]
55. Xue, K., C. Rada, and M. S. Neuberger. 2006. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice. J. Exp. Med. 203:2085-2094.
56. Yang, S. Y., S. D. Fugmann, and D. G. Schatz. 2006. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences. J. Exp. Med. 203:2919-2928.
57. Yu, K., F. Chedin, C. L. Hsieh, T. E. Wilson, and M. R. Lieber. 2003. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4:442-451.[CrossRef][Medline]
58. Yu, K., F. T. Huang, and M. R. Lieber. 2004. DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279:6496-6500.
59. Yu, K., D. Roy, M. Bayramyan, I. S. Haworth, and M. R. Lieber. 2005. Fine-structure analysis of activation-induced deaminase accessibility to class switch region R-loops. Mol. Cell. Biol. 25:1730-1736.
60. Yu, K., A. Taghva, and M. R. Lieber. 2002. The cleavage efficiency of the human immunoglobulin heavy chain VH elements by the RAG complex: implications for the immune repertoire. J. Biol. Chem. 277:5040-5046.
61. Zarrin, A. A., F. W. Alt, J. Chaudhuri, N. Stokes, D. Kaushal, L. Du Pasquier, and M. Tian. 2004. An evolutionarily conserved target motif for immunoglobulin class-switch recombination. Nat. Immunol. 5:1275-1281.[CrossRef][Medline]
62. Zeng, X., G. A. Negrete, C. Kasmer, W. W. Yang, and P. J. Gearhart. 2004. Absence of DNA polymerase eta reveals targeting of C mutations on the nontranscribed strand in immunoglobulin switch regions. J. Exp. Med. 199:917-924.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|